Cosette Names Jeff Neubig as VP of Quality & Regulatory Affairs
Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced on June 30th that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. In this critical role, Jeff will lead Cosette’s best-in-class quality and regulatory affairs organizations, maintaining the company’s rigorous quality standards and further establishing Cosette’s strong position as a respected […]
Mirvie Launches Advanced Solution to Boost Care for Pregnancy Complications
Mirvie, a leader in uncovering the biology and utilizing data-driven approaches to improve the care of women’s health conditions, recently announced the launch of its first breakthrough product for preeclampsia, one of the most common and serious pregnancy complications. Encompass combines a novel blood test to predict personalized preeclampsia risk with a preventive action plan and […]
FMC Corporation announces senior appointments
FMC Corporation an agricultural sciences company, recently announced Darren Dillenbeck, President, FMC U.S.A., has been elected Vice President and President of FMC North America. The company also announced that Renato Guimarães will join FMC as Vice President and President of FMC Latin America. Both appointments are effective April 1. Under Dillenbeck’s leadership, FMC Corporation has grown market share and […]
Veracyte appoints Phillip G. Febbo for two designations
Veracyte, Inc. yeterday announced that Phillip G. Febbo, M.D., will join the company on October 2 as chief scientific officer and chief medical officer. Dr. Febbo, a distinguished industry and academic leader, will lead Veracyte’s global team of research and development, medical affairs, clinical affairs, quality, regulatory affairs, and lab director professionals to help advance […]
HebeCell and Logomix collaborate to develop gene-edited NK cells
HebeCell Corp (HebeCell), a biotechnology company developing ProtoNK™ cell therapeutics based on its proprietary 3D PSC-NK manufacture platform, and Logomix Inc (Logomix), a Tokyo-based synthetic biology company, with a platform technology to engineer-in complex genomic messages of ~Mb-scale into human cells, recently announced a strategic partnership to research and develop gene-edited NK cells and discover genetic […]
Bayer AG appoints Bill Anderson to CEO
The Supervisory Board of Bayer AG has appointed Bill Anderson to become CEO of Bayer, effective June 1, 2023. He will join Bayer as a member of the Board of Management on April 1, 2023. Bill Anderson was elected unanimously after a thorough selection process which began mid last year. Werner Baumann (60), current CEO […]
